CPAP therapy in heavy good vehicle (HGV) drivers with obstructive sleep apnoea (OSA) after 1 year: use of therapy and health status

N. Wiltshire, A. Harper, A. H. Kendrick, J. R. Catterall (Bristol, United Kingdom)

Source: Annual Congress 2001 - Treatment of sleep-disordered breathing
Session: Treatment of sleep-disordered breathing
Session type: Thematic Poster Session
Number: 2827
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Wiltshire, A. Harper, A. H. Kendrick, J. R. Catterall (Bristol, United Kingdom). CPAP therapy in heavy good vehicle (HGV) drivers with obstructive sleep apnoea (OSA) after 1 year: use of therapy and health status. Eur Respir J 2001; 16: Suppl. 31, 2827

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does nasal continuous positive airway (nCPAP) treatment improve health related quality of life (HRQoL) in the bed partners of patients with obstructive sleep apnoea (OSA)?
Source: Eur Respir J 2003; 22: Suppl. 45, 91s
Year: 2003

Something is changing in adherence to CPAP therapy: real world data after 1 year of treatment in patients with obstructive sleep apnoea
Source: Eur Respir J, 55 (3) 1901419; 10.1183/13993003.01419-2019
Year: 2020



Effect of one year CPAP therapy on CO2 drive in obstructive sleep apnea (OSA) according to gender
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009

Differences between commercial vehicle drivers and other patients in symptoms of obstructive sleep apnoea and response to CPAP therapy
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Effect of nCPAP on work performance (WP) in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 725s
Year: 2005

Effect of nCPAP on quality of life (QoL) in professionally active patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 113s
Year: 2005

Does sleepiness have an impact on echocardiographic parameters in obstructive sleep apnea (OSA) after 6M CPAP therapy?
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008


Prevalence and causes of residual sleepiness (RS) 12 months after continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea syndome (OSAS)
Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness
Year: 2010

Influence of smoking on symptoms, comorbidities and severity in a population with obstructive sleep apnea (OSA) versus control
Source: Annual Congress 2011 - Epidemiology of smoking and smoking cessation interventions
Year: 2011


Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


The impact of smoking status on obstructive sleep apnea (OSA) severity.
Source: International Congress 2018 – Sleep and breathing control: phenotypes
Year: 2018

Menopausal status and severity of obstructive sleep apnoea (OSA) in females qualified to CPAP treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 200s
Year: 2006

CPAP compliance and quality of life (QOL) according to educational level in obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 724s
Year: 2005

Impact of humidification on compliance and side effects in obstructive sleep apnea (OSA) patients under auto continuous positive airway pressure (ACPAP) therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 409s
Year: 2006

Comparing coping strategies, accident history and driving simulator (MiniUoLDS) outcome in obstructive sleep apnoea syndrome (OSAS) patients and controls
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014


Quality of life (QOL) and CPAP compliance in workers and employees with obstructive sleep apnea (OSA) syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 112s
Year: 2005

Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020


A novel machine learning approach to predict oral appliance (OA) therapy responses in obstructive sleep apnoea (OSA)
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021


The influence of active and former smoking on the amount and quality of sleep in an obstructive sleep apnea (OSA) population versus habitual snorers
Source: Annual Congress 2012 - Tobacco comorbidity
Year: 2012


The effect of physical rehabilitation (PR) on the severity of symptoms of OSAS in patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea syndrome (OSA)
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016